General
Preferred name
QNZ
Synonyms
EVP4593 ()
CAY10470 ()
6-Amino-4-(4-phenoxyphenylethylamino)quinazoline ()
AG-F-89549 ()
EVP 4593 ()
QNZ (EVP4593) ()
NF-kB activation inhibitor ()
P&D ID
PD010665
CAS
545380-34-5
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION This compound potently inhibits nuclear factor-κB (NFκB) activation and LPS-induced TNFα production . Its discovery is reported in where it is compound 11q. (GtoPdb)
DESCRIPTION QNZ (EVP4593) shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM, respectively. (BOC Sciences Bioactive Compounds)
Cell lines
1
Organisms
2
Compound Sets
11
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
Drug Repurposing Hub
Guide to Pharmacology
LINCS compound set
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
18
Properties
(calculated by RDKit )
Molecular Weight
356.16
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
6
Ring Count
4
Aromatic Ring Count
4
cLogP
4.66
TPSA
73.06
Fraction CSP3
0.09
Chiral centers
0.0
Largest ring
6.0
QED
0.49
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
NF-¦ÊB
Apoptosis
NF-??b
NF-??
NF-κB
Target
NF-??B
TNF-??
NF-?B inhibitor
TNF Receptor
NF-¦ÊB,TNF-alpha
MOA
NFkB pathway inhibitor
Source data